Clinical study| Volume 101, P204-211, July 2022

Download started.


Efficacy and safety of fibrinogen administration in acute post-traumatic hypofibrinogenemia in isolated severe traumatic brain injury: A randomized clinical trial


      • The current study was conducted to evaluate both efficacy and safety of fibrinogen administration in severe traumatic head injury (TBI), and concurrent hypofibrinogenemia.
      • Fibrinogen administration controls hematoma expansion and improves GCS recovery and GOSE in severe TBI.



      This study was conducted to evaluate clinical outcomes after fibrinogen administration in hypofibrinogenemia following severe traumatic brain injury.


      Post traumatic coagulopathy (PTC) is a common but devastating medical condition in patients with severe head injury. Hypofibrinogenemia is considered as an indicator for poor clinical outcomes in traumatic brain injury (TBI).


      In this randomized clinical trial (RCT), primarily 137 patients with severe traumatic brain injury (Glasgow coma scale score: GCS < 9) were enrolled. Thereafter, their plasma fibrinogen level was measured. The patients with primary hypofibrinogenemia (<200 mg/dL) with no concurrent coagulopathy were randomly allocated into fibrinogen-receiving (n = 50) and control (n = 54) groups. P-value < 0.05 was considered as statistically significant.


      Seventy-one patients were analyzed in the final step of the study. The mean value for age in fibrinogen and control groups was 25.64 ± 10.71 and 28.91 ± 12.25 years old, respectively. Male – female patients in both groups were equally distributed. In the fibrinogen receiving group, GCS scores were significantly higher after 24, 48, and 72 h compared to the control group (p = 0.000). Hematoma expansion was better controlled in the fibrinogen receiving group (p = 0.000). Notably, the number needed to treat (NNT) for fibrinogen infusion and hematoma expansion control was 2.3. Glasgow outcome scale-extended (GOSE) was significantly better in the fibrinogen group (p = 0.25). Multiple regression tests showed intracerebral hematoma (ICH) and severe brain edema had the most detrimental effect on GOSE outcomes. The need for cranial surgery, hospital stay duration, mechanical ventilator dependency, in hospital and 90-day post discharge mortality rates were similar in both study groups.


      In severe TBI, hypofibrinogenemia correction (>200 mg/dL) could improve GOSE, GCS score progression within 3 days after primary head injury and hematoma expansion controllability.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bratton S.L.
        • Chestnut R.M.
        • Ghajar J.
        • McConnell Hammond F.F.
        • Harris O.A.
        • Hartl R.
        • et al.
        Guidelines for the management of severe traumatic brain injury. XI. Anesthetics, analgesics, and sedatives.
        J Neurotrauma. 2007; 24: S-71-S-76
        • Maegele M.
        Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options.
        Transfusion. 2013; 53: 28s-37s
        • Pahatouridis D.
        • Alexiou G.A.
        • Zigouris A.
        • Mihos E.
        • Drosos D.
        • Voulgaris S.
        Coagulopathy in moderate head injury. The role of early administration of low molecular weight heparin.
        Brain Inj. 2010; 24: 1189-1192
        • Nascimento B.
        • Callum J.
        • Tien H.
        • Peng H.
        • Rizoli S.
        • Karanicolas P.
        • et al.
        Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial.
        BJA: Br J Anaesthesia. 2016; 117: 775-782
        • Böhm J.K.
        • Güting H.
        • Thorn S.
        • Schäfer N.
        • Rambach V.
        • Schöchl H.
        • et al.
        Global characterisation of coagulopathy in isolated traumatic brain injury (iTBI): a CENTER-TBI analysis.
        Neurocritical Care. 2020;
        • Martini W.Z.
        • Chinkes D.L.
        • Pusateri A.E.
        • Holcomb J.B.
        • Yu Y.-M.
        • Zhang X.-J.
        • et al.
        Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs.
        Am J Physiol Endocrinol Metab. 2005; 289: E930-E934
        • Corbett J.M.
        • Ho K.M.
        • Honeybul S.
        Prognostic significance of abnormal hematological parameters in severe traumatic brain injury requiring decompressive craniectomy.
        J Neurosurg. 2019; 132: 545-551
        • Lv K.e.
        • Yuan Q.
        • Fu P.
        • Wu G.
        • Wu X.
        • Du Z.
        • et al.
        Impact of fibrinogen level on the prognosis of patients with traumatic brain injury: a single-center analysis of 2570 patients.
        World J Emerg Surg. 2020; 15
        • Palmer L.
        • Martin L.
        Traumatic coagulopathy–part 1: pathophysiology and diagnosis.
        J Vet Emerg Crit Care (San Antonio). 2014; 24: 63-74
        • Palmer L.
        • Martin L.
        Traumatic coagulopathy–part 2: resuscitative strategies.
        J Vet Emerg Crit Care (San Antonio). 2014; 24: 75-92
        • Nakae R.
        • Yokobori S.
        • Takayama Y.
        • Kanaya T.
        • Fujiki Y.u.
        • Igarashi Y.
        • et al.
        A retrospective study of the effect of fibrinogen levels during fresh frozen plasma transfusion in patients with traumatic brain injury.
        Acta Neurochirurgica. 2019; 161: 1943-1953
        • Galvagno Jr., S.M.
        • Nahmias J.T.
        • Young D.A.
        Advanced trauma life support(®) update 2019: management and applications for adults and special populations.
        Anesthesiol Clin. 2019; 37: 13-32
        • Volovici V.
        • Steyerberg E.W.
        • Cnossen M.C.
        • Haitsma I.K.
        • Dirven C.M.F.
        • Maas A.I.R.
        • et al.
        Evolution of evidence and guideline recommendations for the medical management of severe traumatic brain injury.
        J Neurotrauma. 2019; 36: 3183-3189
        • Haydel M.J.
        • Preston C.A.
        • Mills T.J.
        • Luber S.
        • Blaudeau E.
        • DeBlieux P.M.C.
        Indications for computed tomography in patients with minor head injury.
        N Engl J Med. 2000; 343: 100-105
        • Sharif-Alhoseini M.
        • Khodadadi H.
        • Chardoli M.
        • Rahimi-Movaghar V.
        Indications for brain computed tomography scan after minor head injury.
        J Emerg Trauma Shock. 2011; 4: 472-476
        • Bullock M.R.
        • Chesnut R.
        • Ghajar J.
        • Gordon D.
        • Hartl R.
        • Newell D.W.
        • et al.
        Guidelines for the surgical management of traumatic brain injury author group.
        Neurosurgery. 2006; 58: S2-vi-S
        • Böhm J.K.
        • Güting H.
        • Thorn S.
        • Schäfer N.
        • Rambach V.
        • Schöchl H.
        • et al.
        Global characterisation of coagulopathy in isolated traumatic brain injury (iTBI): a CENTER-TBI analysis.
        Neurocritical Care. 2021; 35: 184-196
        • van Gent J.A.N.
        • van Essen T.A.
        • Bos M.H.A.
        • Cannegieter S.C.
        • van Dijck J.T.J.M.
        • Peul W.C.
        Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis.
        Acta Neurochirurgica. 2020; 162: 329-336
        • Mackie I.J.
        • Kitchen S.
        • Machin S.J.
        • Lowe G.D.O.
        on behalf of the H, thrombosis task force of the british committee for standards in H. Guidelines on fibrinogen assays.
        British J Haematol. 2003; 121: 396-404
        • Miesbach W.
        • Schenk J.
        • Alesci S.
        • Lindhoff-Last E.
        Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
        Thromb Res. 2010; 126: e428-e433
        • Yuh E.L.
        • Jain S.
        • Sun X.
        • Pisică D.
        • Harris M.H.
        • Taylor S.R.
        • et al.
        Pathological computed tomography features associated with adverse outcomes after mild traumatic brain injury: a TRACK-TBI study with external validation in CENTER-TBI.
        JAMA Neurol. 2021; 78: 1137
        • Caroli M.
        • Locatelli M.
        • Campanella R.
        • Balbi S.
        • Martinelli F.
        • Arienta C.
        Multiple intracranial lesions in head injury: clinical considerations, prognostic factors, management, and results in 95 patients.
        Surg Neurol. 2001; 56: 82-88
        • Klovaite J.
        • Nordestgaard B.G.
        • Tybjærg-Hansen A.
        • Benn M.
        Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis.
        Am J Respir Crit Care Med. 2013; 187: 286-293
        • Ariëns R.A.
        Fibrin(ogen) and thrombotic disease.
        J Thromb Haemost. 2013; 11: 294-305
        • de Moerloose P.
        • Boehlen F.
        • Neerman-Arbez M.
        Fibrinogen and the risk of thrombosis.
        Semin Thromb Hemost. 2010; 36: 7-17